Concepedia

Wei-Ping Lu

WL

Statistics

Publications

6

Citations

603

H-Index

6

Active since

1994

Affiliations

University of Nebraska–Lincoln(Current)

Deciphera Pharmaceuticals (United States)

Wei-Ping Lu is an author at University of Nebraska–Lincoln specializing in biochemistry, life sciences, and carbon monoxide.

Publications per year

1994–2019

6

Publications

6

Ripretinib (DCC-2618) Is a Switch Control Kinase Inhibitor of a Broad Spectrum of Oncogenic and Drug-Resistant KIT and PDGFRA Variants

Bryan D. Smith, Michael D. Kaufman, Wei-Ping Lu et al. · Cancer Cell · 2019 · 277 citations

, , +17

The Selective Tie2 Inhibitor Rebastinib Blocks Recruitment and Function of Tie2Hi Macrophages in Breast Cancer and Pancreatic Neuroendocrine Tumors

Allison S. Harney, George S. Karagiannis, Jeanine Pignatelli et al. · Molecular Cancer Therapeutics · 2017 · 169 citations · Full text

, , +17

Mechanism of Carbon Monoxide Oxidation by the Carbon Monoxide Dehydrogenase/Acetyl-CoA Synthase from <i>Clostridium thermoaceticum</i>:  Kinetic Characterization of the Intermediates

Javier Seravalli, Manoj Kumar, Wei-Ping Lu et al. · Biochemistry · 1997 · 54 citations

, , +15

Mechanism of CO oxidation by carbon monoxide dehydrogenase from Clostridium thermoaceticum and its inhibition by anions

Javier Seravalli, Manoj Kumar, Wei-Ping Lu et al. · Biochemistry · 1995 · 51 citations

, , +9

Binding of Carbon Disulfide to the Site of Acetyl-CoA Synthesis by the Nickel-Iron-Sulfur Protein, Carbon Monoxide Dehydrogenase, from Clostridium thermoaceticum

Manoj Kumar, Wei-Ping Lu, Stephen W. Ragsdale · Biochemistry · 1994 · 41 citations

, , +11

1–5 of 6